Two existing types of drugs synergize to improve the clearing of mucus from the lungs of animals with cystic fibrosis, a ...

Families living with cystic fibrosis and their supporters gathered in Rapid City for the 18th year of the Cystic Fibrosis ...

KB407’s positive set of results presented at ATS 2026 follows a set of similar positive results that were announced for the ...

Australian researchers have mapped how lung damage may begin early in life for children with cystic fibrosis, providing new ...

All the studies only included people with two copies of the most common cystic fibrosis-causing gene variant (F508del). Most studies were entirely or partly funded by medicine companies. No studies ...

Over the past three decades, meaningful progress has been made in the research and understanding of cystic fibrosis (CF). 1 While thousands of patients were able to benefit from t ...

Figure 1. Overview of experimental strategy and derivation of iPSC-derived macrophages (iM0) from healthy and CF donors. (A) Schematic representation of experimental goals; (B) Table of iPSC lines ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly ...

Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies have transformed the outlook for many people living with cystic fibrosis (CF). But while these have delivered substantial ...

Objective: To evaluate the effect of treatment with the combination of three cystic fibrosis transmembrane conductance regulator (CFTR) modulators-elexacaftor+tezacaftor+ivacaftor (ETI)-on important ...